Alizarin Yellow R sodium salt; Mordant Yellow 3R; Alizarin Yellow R; Sodium p-nitrobenzeneazosalicylate; Alizarine Yellow R sodium; UNII-R1T3O0G585; C.I. Mordant Orange 1; NSC 4895; NSC 4991; 5-(p-Nitrophenylazo)salicylic acid sodium salt; EINECS 217-002-4; Sodium 5-((4-nitrophenyl)azo)salicylate; Alizarin yellow R (sodium salt); R1T3O0G585; BENZOIC ACID, 2-HYDROXY-5-((4-NITROPHENYL)AZO)-, MONOSODIUM SALT; Salicylic acid, 5-((p-nitrophenyl)azo)-, sodium salt; 2-Hydroxy-5-((4-nitrophenyl)azo)benzoic acid sodium salt; Salicylic acid, 5-((p-nitrophenyl)azo)-, monosodium salt; Benzoic acid, 2-hydroxy-5-[(4-nitrophenyl)azo]-, monosodium salt; C.I. Mordant Orange 1, monosodium salt; Benzoic acid, 2-hydroxy-5-(2-(4-nitrophenyl)diazenyl)-, sodium salt (1:1); Benzoic acid, 2-hydroxy-5-[2-(4-nitrophenyl)diazenyl]-, sodium salt (1:1); Alizarin Yellow R, sodium salt; CHEMBL176350; NSC4895; 5-(4-Nitrophenylazo)salicylic acid; 2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoic acid, sodium salt; ALIZARINYELLOWR; ACMC-1BQOV; SCHEMBL264266; CHEMBL2028449; DTXSID9024433; CTK8C5428; sodium 2-hydroxy-5-[(E)-(4-nitrophenyl)diazenyl]benzoate; LS-930; MFCD00067121; SBB008990; AKOS015903793; AKOS024387378; AKOS025116704; AKOS030241948; Alizarin Yellow R sodium salt, 96%, pure; A0207; A0579; ST51039877; C.I. Mordant Orange 1, monosodium salt (8CI); W-107870; Q27287677; sodium;2-carboxy-4-[(4-nitrophenyl)diazenyl]phenolate; sodium (E)-2-hydroxy-5-((4-nitrophenyl)diazenyl)benzoate